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Three main  classes  of human  serum  immunoglobulins are currently recog- 
nized:  the IgG  (3,~-globulins),  IgA  ('Y1A, /?~A-globulins) and  IgM  ('Y1M, /32M, 
or  18S ?-globulins). In addition there are low molecular weight immunoglob- 
ulins, most readily found in the urine. Each of these normal immunoglobulins 
has  counterparts  associated  with  plasmacytic  or  lymphocytic neoplasms,  i.e. 
G  (~/2) myeloma proteins,  A  (3'1A-,/32A-) myeloma proteins, and  M  (Walden- 
strSm's)  macroglobulins of serum and  Bence Jones proteins of the urine.  An 
atypical myeloma protein which does not fall within this present classification 
of immunoglobulins, therefore, would be of particular interest because it might 
represent either a  very abnormal  protein or a  new  class  of immunoglobulin. 
Such a  unique myeloma protein, found in the serum of patient S. J. with his- 
tologically proven multiple myeloma, is the subject of the present report. 
Several observations  had previously indicated  that the myeloma protein in patient 
S.  J.  might be atypical.  These observations  took two  forms.  Papain  treatment of 
human  G myeloma proteins revealed  that most proteins of this class yield fast Fc 
fragments of uniform electrophoretic  mobility,  but the Fc fragments of S. J. mye]oma 
protein migrated more  rapidly than  typical Fc fragments  (1).  Secondly,  studies  of 
the turnover of normal lgG in patients with multiple  myeloma revealed  a  uniform 
effect of G myeloma proteins in accelerating  IgG catabolism,  except in  the case of 
S. J. and another patient (2). This was evidence that the S. J. protein differed from the 
typical G myeloma proteins and from the bulk of normal IgG in terms of the struc- 
tures effecting IgG catabolism. 
On the basis of these indications that the S. J. myeloma protein had unusual 
properties, detaileJ immunochemical and physicochemical studies were under- 
taken. The results show that the S. J. myeloma protein possesses a light poly- 
peptide chain structure similar to that of other serum immunoglobulins but is 
unique in properties of the heavy polypeptide chains. 
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Materials and Methods 
The myeloma serum was obtained from S. J., a white male aged 57. At the time when serum 
was obtained for study, he had a 3 month history of low back pain. Bone marrow aspiration 
showed sheets of immature plasma cells,  Bence Jones protein was present in the urine, and 
there was generalized osteoporosis, with collapse of the second lumbar vertebra. Subsequently, 
extensive osteolytic lesions typical of myeloma were observed. Autopsy 14 months from the 
time of serum study showed widespread and poorly differentiated plasma cell myeloma. 
Quantitative  paper  electrophoresis,  starch  gel  electrophoresis,  immunoelectrophoresis, 
Ouchterlony tests, and analytical ultracentrifugation were carried out according to standard 
procedures (3).  The myeloma protein was isolated from the serum by block electrophoresis, 
followed  by  column  chromatography on  DEAE  cellulose as  described  for  the  isolation  of 
A myeloma proteins (3). Preparation of normal IgG and IgM has been described (3) and IgA 
was generously made available by Dr. J. P. Vaerman and Dr. H. Fudenberg. 
Papain digestion was by the method of Porter  (4),  restricting the time of digestion to  1 
hour. Reduction and alkylation were by a  modification of the method of Fleischman, Pain, 
and Porter (5). The myeloma protein (20 mg/ml in 0.5 M pH 8.0 tris HC1 buffer) was treated 
with 0.1  M mercaptoethanol for 1 hour at room temperature, and then cooled in an ice bath. 
An equal volume of 0.1 i  iodoacetamide in the same buffer at 0°C was added, and the mixture 
maintained at 0°C for 1 hour. The mixture was then dialyzed against several changes of 100 
volumes of distilled water at 4°C for 6 hours, then dialyzed against 200 volumes of 1 M acetic 
acid for 16 hours at 4°C. 
Heavy and light chains were separated on a column formed of a mixture of sephadex G-100 
(1 part by weight) and sephadex G-200 (2 parts) equilibrated with 1 M acetic acid as suggested 
by Small et al. (6). Four ml of solution containing 40 mg of reduced and alkylated protein was 
applied to a column 79 x  1.8 cm. The eluate was collected in 4 ml fractions. The separation 
was carried  out at 4°C. 
Rabbit antiserums to IgG, IgA, and IgM were obtained by methods already described (3). 
Antiserum to the S. J. myeloma protein was obtained from two rabbits immunized with the 
isolated myeloma protein. Five and four-tenths mg protein in 2 ml saline emulsified with 2 ml 
Freund's complete adjuvant were injected intramuscularly in two sites,  and  the injections 
repeated after 4 weeks. After 6 weeks, the animals received a course of 5 injections on alternate 
days containing a  total of 3 mg of alum-precipitated protein. The animals were bled 6 days 
after the end of the course. These antiserums were made specific for the S. J. myeloma protein 
by two methods. Absorption with a  type L  (II)  G  myeloma protein removed antibodies to 
type L (II) light chain determinants and to IgG, and was followed  by absorption with serum 
from  a  case  of  hypogammaglobulinemia to  remove  small amounts  of  antibody to  a-  and 
S-globulins. Alternatively the antiserum was absorbed with  1/10 volume of normal human 
serum. Although most human serums contain the related class of immunoglobulin, the con- 
centration of this component is insufficient to reduce materially the amount of specific  anti- 
body by this absorption (7). 
RESULTS 
S. J. Serum and Myeloma Protein.--Total  serum protein concentration  was 
8.0  gm/100  ml.  Paper  electrophoresis  (Fig.  1)  showed  an  abnormal  peak  of 
protein  migrating  in  the  slower portion  of  the ~-globulin  region.  The  concen- 
tration of the anomalous protein was 3.9 gin/100 ml. Starch gel electrophoresis 
(Fig.  1)  similarly  showed  a  discrete  abnormal  protein  band,  which  readily 
penetrated  the gel and had a  mobility consistent with a/~-globulin. DAVID  S.  ROWE  AND  JOHN  L.  FAHEY  173 
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o r]  .~ FIG.  2.  Ultracentrifugal  analysis of  the  isolated  S.  J.  myeloma protein,  compared  with 
IgG from normal serum. Analysis was carried out at 59,780 RPM in a  Spinco model E  ultra- 
centrifuge. Photograph obtained 44 minutes after reaching full speed. The S. J. myeloma pro- 
tein  sediments as  a  symmetrical peak  of  7.04S.  Protein  concentration  was  approximately 
5  mg/ml in 0.14 M NaC1.  N. H.  S.,  normal human serum. 
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Ultracentrifugation  of  S.  J.  serum  (Fig.  1)  showed  an  elevated  7S  peak, 
comprising 33  per cent  of  the  total protein.  The  isolated protein sedimented 
as  a  symmetrical peak  with  a  sedimentation  coefficient (S2o,w) of  7.04S  at  a 
protein concentration of 0.5  gm/100  ml  (Fig. 2). 
FIG. 4.  Ouchterlony  analyses showing the antigenic distinctiveness of S. J. myeloma pro- 
tein. Antiserums  specific to IgG, IgA, and IgM fail to react with S. J. myeloma protein, but 
do react with proteins of appropriate class isolated from normal serum.  Antiserum specific 
to S. J. myeloma protein reacts with this protein, but not with IgG, IgA, or IgM. Protein 
concentration 05 mg/ml. The antiserum (AS) is indicated below each test. M. P., myeloma 
protein. 
Immunoelectrophoretic  studies  of  the  whole  serum  and  isolated  protein 
were  carried  out  with  polyvalent  and  specific  antiserums.  Immunoelectro- 
phoretic analyses using an antiserum reactive with IgG, IgA, and IgM revealed 
only one  precipitin line which  was  slightly broadened  toward  the  anodal end 177 
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(Fig.  3).  Immunoelectrophoretic  testing  of  S.  J.  serum  against  antiserums 
reacting  specifically with  IgG,  IgA,  or  IgM  failed  to  reveal  any  myeloma 
protein. 
Antiserums prepared  in rabbits  to  the  isolated S.  ].  myeloma protein  re- 
vealed the myeloma protein as a heavy precipitin arc in the/S-globulin region 
of S. J. serum (Fig. 3). The antiserum to S. ]. myeloma protein also produced 
a  faint precipitin line with the IgG of S. ]. serum and of normal serum (Fig. 
3).  Absorption  of  the  antibodies reactive  with  IgG  rendered  the  antiserum 
unreactive with IgG, IgA, and IgM (Fig. 4). The absorbed antiserum, however, 
was still reactive with the S. J. myeloma protein. 
Direct comparison of the  S.  ].  myeloma protein with representative  IgG, 
IgA, and IgM preparations from normal  serum  (Fig. 4)  confirmed the anti- 
genic distinctiveness of the S. J. myeloma protein. The protein was not reac- 
tive with antiserums directed at  the  specific  antigenic determinants of IgG, 
IgA, or IgM. Antiserums specific to the S. J. myeloma protein were unreactive 
with IgG, IgA, and IgM. 
Further  immunoelectrophoretic studies  demonstrated  that,  in  addition  to 
distinctive antigenic properties,  the S.  J. myeloma protein shared some anti- 
genic properties in common with the major immunoglobulin classes  of normal 
serum.  Immunoelectrophoretic analysis was  carried  out  using  an  antiserum 
known to react with type K  (I) and type L (II) light chain determinants. This 
antiserum revealed only the  IgG arc  in normal serum  (not  illustrated), but 
S. ]. serum showed an extra line in the form of two arcs close to the antiserum 
trough (Fig. 5).  The more cathodal of these arcs corresponded in mobility to 
the  myeloma protein.  Absorption  of  the  antiserum  by a  type  K  (I)  Bence 
Jones protein did not change the immunoelectrophoretic pattern, but absorp- 
tion by a  type L  (II) Bence Jones protein, caused the extra line to disappear 
(Fig. 5, lower half). This was evidence that the serum S.  J. myeloma protein 
possessed  type L  (II)  antigenic determinants.  The  presence  of  type  L  (II) 
determinants on the S. J. myeloma protein was confirmed in studies of isolated 
light polypeptide chains  (see  below). This finding emphasized the  structural 
relationship between S. J. myeloma protein and the immunoglobulin family. 
The immunoelectrophoretic studies revealed an additional anomalous pro- 
tein which migrated on the anodal side of the myeloma protein  (Figs. 3 and 
5). The precipitin line of this protein fused with the precipitin line of the S. J. 
myeloma protein  (Figs. 3 and 5).  This component was identified as a  Bence 
Jones protein and was shown to have the same electrophoretic mobility and 
antigenic determinants, type L  (II), as the Bence Jones protein present in the 
urine of this patient. 
Substructure of the S. J. Myeloma Protein.--The composition of S. J, myeloma 
protein was investigated by reduction and alkylation to obtain the constituent 
polypeptide  chains,  and  by  papain  digestion.  The  molecular  subunits  were 
compared with the components of IgG obtained by the same technics. DAVID  S.  ROWE  AND  JOHN  L.  FAHEY  179 
Reduction and alkylation caused dissociation of the constituent polypeptide 
chains into two groups, designated heavy and light on the basis of properties 
described below. These subunits were separated by filtration through a sephadex 
column in 1.0 M acetic acid (Fig. 6) or by starch gel electrophoresis with acid 
urea buffer in  the manner of Poulik and Edelman  (8).  The last eluted peak 
from the sephadex column, tubes 42 to 55 in Fig. 6, contained 23 per cent of 
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FI6. 6. Comparison of the products of reduction and alkylation of S. J. myeloma protein 
and of normal IgG. Gel filtration was performed on the same sephadex column in 1 M  acetic 
acid. Heavy chains from both proteins form 77 per cent of the total eluted material. 
the  total  protein.  The  proteins  in  this  peak  had  starch  gel  electrophoretic 
characteristics of L  polypeptide chains.  Immunochemical tests using specific 
antiserums,--reacting specifically with S.  J. myeloma protein or with type K 
(I)  or  type  L  (II)  antigenic  determinants,--revealed  that  the  polypeptide 
chains  in  this  last  peak  contained  only type L  (II)  antigenic determinants, 
also indicating that the light polypeptide chains were in this column fraction. 
The first eluted small peak and the first major protein peak, tubes 20 to 40 
in Fig. 6, contained the heavy polypeptide chains. These fractions comprised 77 
per cent of the total protein. The heavy chains of S.  J. myeloma protein mi- 
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and, indeed, migrated more slowly than heavy chains from G myeloma proteins. 
Heavy chain fractions did not precipitate on Ouchterlony analysis with specific 
antiserum to S. J. myeloma protein, but they did inhibit the ability of the anti- 
serum to precipitate the intact S.  J. myeloma protein. Thus, antigenic deter- 
minants characteristic of the S. J. myeloma protein were present in the heavy 
polypeptide chains. 
In sum, these observations on the subunits obtained by reduction and al- 
kylation indicate that the S. J. myeloma protein is composed of heaw chains 
of an  unusual and  distinctive antigenic type and  of  light  chains  of  type  l, 
(II). 
The subunits from S. J. myeloma protein and normal serum IgG obtained 
by reduction and alkylation (Fig. 6)  were compared. The heavy polypeptide 
chains were eluted in tubes 20 to 40,  and comprised 77  per cent of the total 
protein  in  both  cases.  These  fractions  also  contained distinguishing specific 
antigenic determinants. The  light polypeptide chains were  similarly compa- 
rable, being eluted in tubes 42  to 55 and in having light chain-specific deter- 
minants, both types K (I) and 1. (II) in the case of normal IgG and only type 
L  (II) in the case of the S. J. myeloma protein. 
Several characteristics of the sephadex fractions from reduced and alkvlated 
S. J. myeloma protein deserve additional comment. (a) No fractions contained 
material  precipitable  by  antiserum  specific  for  IgG,  IgA,  or  IgM  antigenic 
determinants. Thus  the  specific  determinants of  the  three  known classes  of 
immunoglobulins were not detected in the S.  J. myeloma protein even after 
reduction and alkylation procedures.  (b)  No fractions contained material pre- 
cipitable  bv  antiserum  for  type  K  (I)  light  chain  antigenic  determinants, 
indicating the absence of contamination of the S. J. mveloma protein prepara- 
tion with normal immunoglobulins. (c)  Light polypeptide chains isolated from 
the S. J. myeloma protein reacted much more strongly with antiserum against 
type L  (II)  antigenic determinants (anti-type L  Bence .Jones protein),  than 
did the intact protein. This phenomenon is believed to be due to the exposure 
of light chain determinants which are "buried" in the intact molecule, and is 
discussed further in the accompanying paper (7). 
Papain digestion of the S.  J. myeloma protein yielded fragments sediment- 
ing at 3.4S in the ultracentrifuge. Immunoelectrophoretic analysis, using anti- 
serum to the mveloma protein, revealed two antigenically and electrophoreti- 
eally  distinct  fragments  (Fig.  7).  After  separation  by  chromatography" on 
DEAE  cellulose  both fragments sedimented at approximately 3.7S.  In  these 
respects the fragments were similar to the Fab (slow) and Fc (fast) fragments 
of IgG. The  Fc fragments of the  S.  J.  myeloma protein,  however, migrated 
more rapidly toward the anode than did the Fc fragments of IgG (Fig. 7). In 
this respect the Fc fragments of S.  J. mveloma protein also differed from the 
Fc fragments of the majority of G myeloma proteins  (1, 9,  10). The unusual DAVID  S.  ROWE  AND  JOHN  L.  FAI-IEY  181 
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mobility of the Fc fragment provides further evidence of distinctive properties 
of the heavy chain of S. J. myeloma protein. 
DISCUSSION 
Myeloma proteins  comprise  a  group  of  pathological  globulins  which  are 
identified by their special antigenic and structural relationships to the immuno- 
globulins of normal plasma, and by their origin in neoplastic plasma cells. The 
anomalous protein of S.  J.  serum had a  dual relationship to other myeloma 
proteins, i.e., it was similar to typical myeloma proteins in many respects, but 
it also had unique properties.  Features characteristic of all myeloma proteins 
included  heavy  and  light  polypeptide  chain  composition.  The  light  chains 
had  typical type L  (II)  antigenic determinants. Papain  treatment produced 
Fab and Fc fragments in the same ratio as for IgG. A Bence Jones protein of 
the same type (type L) was present in serum and in urine. Finally, sheets of 
plasma cells found on marrow biopsy are presumed to be the site of myeloma 
protein synthesis. 
Three features of the S.  J. myeloma protein helped  to distinguish it from 
G  myeloma proteins, A  myeloma proteins,  or M  macroglobulins of Walden- 
strSm. The first of these was immunochemical; i.e.,  the absence of specific IgG, 
IgA, or IgM determinants. The second feature was the unusually rapid elec- 
trophoretic mobility of the Fc fragment obtained by papain digestion. Most, 
but not all, G myeloma proteins yield Fc fragments of slower mobility (1, 11). 
The third was the lack of effect of this myeloma protein on the rate of catabo- 
lism of normal IgG (2). All three of the atypical features of the S. J. myeloma 
protein reflect specific properties of the heavy polypeptide chains. 
An unusual protein of this type might possibly arise from a  major disorder 
of  the protein  synthetic mechanism within the malignant plasma cells  with 
the result that a  completely abnormal heavy polypeptide chain was formed. 
Alternatively,  the  S.  J.  myeloma protein  might  represent  the  quantitative 
increase of a previously unrecognized normal class of inmmnoglobulins. 
A number of observations indicated that the heavy chains were normal in 
many features, i.e.,  they combined with light chains in a  similar ratio as do 
those in IgG and other immunoglobulins (12-14); they were of approximately 
the same size as 3,-heavy chains, as seen by their behavior on sephadex column 
filtration and by their presence in a  7S molecule; and papain hydrolyzed the 
S.  J. myeloma protein in a manner similar to its action on IgG. Finally, and 
most persuasively, an antigenically related protein  in low  concentration has 
been demonstrated in many normal serums as described in the following paper 
(7). These observations indicate that the S. J. myeloma protein does not repre- 
sent  a  gross  abnormality of  heavy  chain  synthesis by  the  neoplastic  cells. 
Apparently the S. J. plasmacytoma was unusual in its production of a mveloma 
protein representative of a class of immunoglobulins which form only a  small 
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These observations do not constitute proof that the S. J. myel9ma protein 
is normal in every respect.  Myeloma proteins may have individually specific 
antigenic determinants  (15).  The S.  J.  myeloma protein may have such de- 
terminants, but these do not account for all of the immunochemical unique- 
ness of this myeloma protein. In particular,  antigenic individuality of the Fc 
fragment obtained by papain digestion probably represents class-specific  anti- 
genic determinants, since the Fc fragment contains the class-specific  antigenic 
character of IgG in man (16) and IgG and IgA of the mouse (17). 
A  survey of available  myeloma serums  was  undertaken  to  determine  the 
frequency with which the S. J. type myeloma proteins appeared. Of 91 addi- 
tional myeloma proteins tested, none have been found to be specifically related 
to the S.  J. myeloma protein. This indicates that the S.  J. myeloma protein 
represents an uncommon class of myeloma protein. 
SUMMARY 
The unique myeloma protein from S. J., a  patient with multiple myeloma, 
was isolated and characterized. It resembled other myeloma proteins in many 
respects.  The S.  J. myeloma protein migrated in a  distinct peak in the slow 
fl-globulin region on zone electrophoresis, appeared as a  single band on starch 
gel  electrophoresis,  and  sedimented at  7.04S in  the  ultracentrifuge.  Papain 
and cysteine treatment produced Fc (fast) and Fab  (slow) fragments. Reduc- 
tion and alkylation of the myeloma protein produced heavy and light chains 
in a  ratio of approximately 3:1. The S. J. myeloma protein had type L  (type 
II)  light chains. These were antigenically similar to the Bence Jones protein 
also found in this patient. 
The S. J. myeloma protein was unique in the properties of its heavy chains. 
The myeloma protein  (and  its heavy chains and  Fc pieces)  did not contain 
antigenic determinants specific  for IgG,  IgA, or IgM.  The myeloma protein 
(and  its  heavy chains),  however,  did  contain antigenic  determinants  which 
are characteristic of a new class of immunoglobulin. The S. J. myeloma protein 
was unusual also  in  its effect on the metabolism of normal IgG and  in  the 
electrophoretic mobility of the Fc fragment produced by papain digestion. 
No evidence was obtained to indicate that the entire heavy polypeptide of 
the S. J. protein was a grossly abnormal product of malignant cell metabolism. 
The unique properties of the S. J. myeloma protein (and its heavy chains) are 
believed to represent, in large measure, properties to be found in a small part 
of the normal immunoglobulin population. 
The authors wish to acknowledge the assistance of Dr. Alan Solomon and Miss Carla L. 
McLaughlin in  studies of the protein and  Dr.  Paul  Carbone,  Medicine Branch,  National 
Cancer Institute, in generously making available serum from this patient. 
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